Skip to main content
logo
Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.420
+0.130 (3.95%)
At close: Mar 13, 2026, 4:00 PM EDT
3.400
-0.020 (-0.58%)
After-hours: Mar 13, 2026, 7:59 PM EDT

Recursion Pharmaceuticals Revenue

In the year 2025, Recursion Pharmaceuticals had annual revenue of $74.68M with 26.92% growth. Recursion Pharmaceuticals had revenue of $35.54M in the quarter ending December 31, 2025, with 681.74% growth.

Revenue (ttm)
$74.68M
Revenue Growth
+26.92%
P/S Ratio
24.15
Revenue / Employee
$124,468
Employees
600
Market Cap
1.80B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202574.68M15.84M26.92%
Dec 31, 202458.84M14.26M32.00%
Dec 31, 202344.58M4.73M11.88%
Dec 31, 202239.84M29.67M291.46%
Dec 31, 202110.18M6.22M156.89%
Dec 31, 20203.96M1.64M70.85%
Dec 31, 20192.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sarepta Therapeutics2.20B
Aurinia Pharmaceuticals283.06M
AnaptysBio234.60M
Soleno Therapeutics190.41M
Ocular Therapeutix51.95M
Relay Therapeutics15.36M
Capricor Therapeutics11.13M
Revenue Rankings

RXRX News

More News